Evidence map›Paper›PMID 20706276›Full record

ArticleCell death and differentiation2010

BH3-only protein Bmf mediates apoptosis upon inhibition of CAP-dependent protein synthesis.

F Grespi, C Soratroi, G Krumschnabel, B Sohm, C Ploner, S Geley, L Hengst, G Häcker, A Villunger

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Involvement of the Actin Machinery in Programmed Cell Death.Frontiers in cell and developmental biology · 2020
    Review
  13. Redox-Mediated Mechanism of Chemoresistance in Cancer Cells.Antioxidants (Basel, Switzerland) · 2019
    Review
  14. Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy.International journal of molecular sciences · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

F GrespiInnsbruck Medical University, Biocenter, Austria.
C Soratroi
G Krumschnabel
B Sohm
C Ploner
S Geley
L Hengst
G Häcker
A Villunger
Innsbruck Medical University · ATInstitute of Medical Microbiology and Hygiene · DE

Funding

Austrian Science Fund FWF W 1101
6 · The paper itself

Abstract

Tight transcriptional regulation, alternative splicing and/or post-translational modifications of BH3-only proteins fine-tune their proapoptotic function. In this study, we characterize the gene locus of the BH3-only protein Bmf (Bcl-2-modifying factor) and describe the generation of two major isoforms from a common transcript in which initiation of protein synthesis involves leucine-coding CUG. Bmf(CUG) and the originally described isoform, Bmf-short, display comparable binding affinities to prosurvival Bcl-2 family members, localize preferentially to the outer mitochondrial membrane and induce rapid Bcl-2-blockable apoptosis. Notably, endogenous Bmf expression is induced on forms of cell stress known to cause repression of the CAP-dependent translation machinery such as serum deprivation, hypoxia, inhibition of the PI3K/AKT pathway or mTOR, as well as direct pharmacological inhibition of the eukaryotic translation initiation factor eIF-4E. Knock down or deletion of Bmf reduces apoptosis under some of these conditions, demonstrating that Bmf can act as a sentinel for stress-impaired CAP-dependent protein translation machinery.

Indexed as

ApoptosisAdaptor Proteins, Signal TransducingAlternative SplicingAnimalsApoptosis Regulatory ProteinsBase SequenceBcl-2-Like Protein 11bcl-Associated Death ProteinBH3 Interacting Domain Death Agonist ProteinCell LineEukaryotic Initiation Factor-4EGenes, bcl-2HumansMembrane ProteinsMiceMitochondrial MembranesAdaptor Proteins, Signal TransducingApoptosis Regulatory ProteinsBCL2L11 protein, humanBcl2l11 protein, mouseBcl-2-Like Protein 11bcl-Associated Death ProteinBH3 Interacting Domain Death Agonist ProteinBMF protein, humanBmf protein, mouseEukaryotic Initiation Factor-4EMembrane ProteinsMTOR protein, humanProtein IsoformsProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2RNA Cap-Binding ProteinsRNA, MessengerTOR Serine-Threonine Kinases

Identifiers

PMID20706276
PMCPMC2953534
OpenAlexW2069368205

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.